The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Cement embolism
Publications
Acute pulmonary embolism following -butyl-cyanoacrylate endoscopic injection sclerotherapy.
Annals of gastroenterology 2012;25;261 — 2012 — 261
Education and imaging: gastrointestinal: pulmonary embolism of cyanoacrylate glue following endoscopic injection of gastric varices.
Journal of gastroenterology and hepatology 2012 Dec;27;1874 — 2012 Dec — 1874
[Pulmonary embolism by cyanoacrylate following embolisation of an arteriovenous malformation].
Revue des maladies respiratoires 2009 Jan;26;74-7 — 2009 Jan — 74-7
Cyanoacrylate in the treatment of gastric varices complicated by multiple pulmonary emboli.
Internal medicine journal 2006 Jul;36;462-5 — 2006 Jul — 462-5
Fatal N-butyl-2-cyanoacrylate pulmonary embolism after sclerotherapy for variceal bleeding.
Endoscopy 2005 Jul;37;687 — 2005 Jul — 687
Pulmonary embolization of 2-octyl cyanoacrylate after endoscopic injection therapy for gastric variceal bleeding.
Mayo Clinic proceedings 2004 Nov;79;1455-8 — 2004 Nov — 1455-8
N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding.
Journal of computer assisted tomography 2001 Jan-Feb;25;16-22 — 2001 Jan-Feb — 16-22